Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00889447 · ClinicalTrials.gov registry record

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)

A clinical trial of Chronic Obstructive Pulmonary Disease, sponsored by Johns Hopkins University.

Completed
Registry status
670
Enrollment target
1
Study location

NCT00889447 is a study of Chronic Obstructive Pulmonary Disease that has completed, run by Johns Hopkins University. The registered enrollment target is 670 participants, below the 1,746-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00889447, a study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
670 participants
Enrollment target
1
Study location

Study Summary

This research is being done to study mechanisms of progression of COPD and to develop treatments for it. The investigators are doing the present study to identify people age 40 and older with mild to moderate COPD who will qualify for such studies to include in a database. The study will include establishing a screening evaluation or characterization of the following two studies: * Emphysema Progression in COPD- Losartan's Effects on Airway Parameters - NA\_00009980 * Sleep-Related Physiology and Inflammation in Chronic Obstructive Pulmonary Disease - NA\_00001771

Study Locations (1)

Maryland

  • Johns Hopkins Asthma and Allergy Center - Baltimore

Trial Details

FieldValue
Enrollment Target 670 participants
Start Date 2008-01
Est. Completion 2017-05

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT00889447

The ClinicalTrials.gov registry entry for NCT00889447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 670 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,746-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (62% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00889447 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00889447 about?

NCT00889447 is a clinical study titled "Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)". This research is being done to study mechanisms of progression of COPD and to develop treatments for it. The investigators are doing the present study to identify people age 40 and older with mild to moderate COPD who will qualify for such studies to include in a database. The study will include est...

What is the current status of trial NCT00889447?

This trial is currently completed. The enrollment target is 670 participants. The study started on 2008-01. Estimated completion is 2017-05.

What conditions does trial NCT00889447 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

Who is sponsoring clinical trial NCT00889447?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00889447 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.